Advanced Neuromodulation buys two companies:
This article was originally published in Clinica
Advanced Neuromodulation Systems (ANS), which makes implantable systems for the management of chronic intractable pain, has bought the assets of two private companies for a total of 119,100 ANS shares. The transactions will give Dallas, Texas-based ANS access to infusion pump technologies jointly developed by Implantable Devices Limited Partnership, of Minneapolis, Minnesota, and Eagan, Minnesota-based ESOX Technology. ANS previously had a licensing agreement for the technology.